- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03068195
Efficacy and Safety of Microwave Ablation in BosniakⅠ~ⅡF Cystic Renal Lesions
Efficacy and Safety of Microwave Ablation in BosniakⅠ~ⅡF Cystic Renal Lesions: Clinical Outcomes of a Randomised Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Simple renal cysts are the most common renal masses, and occur in half of all patients older than 50 years.They are usually asymptomatic and benign, asymptomatic and discovered incidentally. However, over time, these simple cysts can enlarge, become symptomatic and develop complications, requiring intervention.They can be managed by a variety of surgical and percutaneous methods, including percutaneous aspiration (with or without injection of a sclerosing agent), endoscopic marsupialization or excision, open surgery and laparoscopic cyst excision.Percutaneous aspiration and sclerotherapy have been described as safe and effective methods of managing symptomatic simple renal cysts without the cost and morbidity associated with conventional surgery and laparoscopy.However, laparoscopic decortications and simple aspiration is associated with a high recurrence rate because the cyst wall epithelium is responsible for active liquid production.
Purpose:To determine whether microwave ablation is more effective in the treatment of simple renal cysts than conventional laparoscopic decortication.
Method:
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yonghui Chen
- Email: cyh1488@163.com
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China
- Recruiting
- Yonghui Chen
-
Contact:
- Yonghui Chen
- Email: cyh1488@163.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients with sporadic, unilateral, newly diagnosed Bosniak Ⅰ, Ⅱ and ⅡF renal cyst
- patients agreeable to participate in this long-term follow-up study
- patients with normal contralateral renal function (differential renal function of >40% as determined by radionuclide scintigraphy)
Exclusion Criteria:
- patients' aged >80 years
- patients not able to tolerate the microwave ablation procedure
- patients with previous renal surgery or history of any inflammatory conditions of the operative kidney
- patients with the renal cyst involving urinary collecting system
- patients with other renal diseases,(including kidney stone, glomerular nephritis, etc.) which might affect the renal function of the operative kidney
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: laparoscopic microwave ablation
laparoscopic microwave ablation will be performed before the renal cysts are decorticated
|
KY2000 microwave ablation system was used in the experimental group.
A power output of 60 W for 1-3 min for 1-3 cycles to treat the renal cysts according to the cysts size and classification.Percutaneous microwave ablation will be performed under the guidance of ultrasound while the laparoscopic microwave ablation will be performed under direct vision
|
EXPERIMENTAL: percutaneous microwave ablation
percutaneous microwave ablation will be performed to treat the renal cysts without decorticating.
|
KY2000 microwave ablation system was used in the experimental group.
A power output of 60 W for 1-3 min for 1-3 cycles to treat the renal cysts according to the cysts size and classification.Percutaneous microwave ablation will be performed under the guidance of ultrasound while the laparoscopic microwave ablation will be performed under direct vision
|
ACTIVE_COMPARATOR: laparoscopic decortication
conventional laparoscopic decortication will be performed to treat the renal cysts.
|
conventional laparoscopic decortication will be performed to treat the renal cysts
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
local recurrence
Time Frame: 12 months postoperatively
|
12 months postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
operative time
Time Frame: during operation
|
during operation
|
postoperative complications
Time Frame: postoperative,up to 30 days
|
postoperative,up to 30 days
|
Hospital stay time
Time Frame: time from the date of admission until the date of discharge, up to 2 weeks
|
time from the date of admission until the date of discharge, up to 2 weeks
|
quality of life assessed by quality of life questionnaire
Time Frame: postoperative,up to 6 months
|
postoperative,up to 6 months
|
change from baseline glomerular filtration rate (GFR) of the affected kidney, 12 months minus baseline
Time Frame: baseline and 12 months
|
baseline and 12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Yiran Huang, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RenJiH-20161017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Diseases,Cystic
-
University of North Carolina, Chapel HillVanderbilt University; North Carolina Translational and Clinical Sciences InstituteCompletedChronic Kidney Disease | Cystic Kidney DiseaseUnited States
-
Helsinki University Central HospitalNot yet recruitingKidney Cancer | Surgery | Cystic Renal Disease
-
University of North Carolina, Chapel HillLantheus Medical ImagingCompletedChronic Kidney Diseases | Cystic Kidney DiseaseUnited States
-
SanofiTerminatedCongenital Cystic Kidney DiseaseGermany, Spain, United States, Australia, Belgium, Japan, Korea, Republic of, Netherlands
-
University Hospital Inselspital, BerneCompletedKidney Neoplasms | Cystic Renal DiseasesSwitzerland
-
Advice Pharma Group srlRecruitingDiabetes | Chronic Kidney Diseases | Tuberous Sclerosis | Albuminuria | Treatment Adherence | Arterial Hypertension | Treatment Adherence and Compliance | Nephronophthisis | Polycystic Kidney | Chronic Glomerulonephritis | Cystic Kidney Diseases | Cortical Cystic Disease | Cystic DiseasesItaly
-
University of Kansas Medical CenterCompletedPolycystic Kidney DiseasesUnited States
-
Alan Yu, MB, BChirCompletedPolycystic Kidney DiseaseUnited States
-
University of Texas Southwestern Medical CenterDepartment of UrologyNo longer availableHydronephrosis | Multicystic-dysplastic Kidney
-
University of Kansas Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedPolycystic Kidney DiseaseUnited States
Clinical Trials on microwave ablation
-
Wenjun WuFirst Affiliated Hospital of Wenzhou Medical UniversityUnknown
-
Assiut UniversityNot yet recruitingThyroid Nodule (Benign)
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
Karolinska InstitutetRecruitingPortal Hypertension | Splenomegaly; Congestive, Chronic | Panhematopenia; SplenicSweden
-
The First People's Hospital of ChangzhouCompletedColorectal Cancer
-
Qianfoshan HospitalShandong Provincial HospitalNot yet recruitingAdvanced Non Small Cell Lung CancerChina
-
Zagazig UniversityCompletedHepatocellular Carcinoma
-
Chinese University of Hong KongThe Hong Kong Society of GastroenterologyCompletedHepatocellular CarcinomaHong Kong
-
Chinese University of Hong KongCompletedHepatocellular CarcinomaChina